1. Home
  2. BCTXW vs FPAY Comparison

BCTXW vs FPAY Comparison

Compare BCTXW & FPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCTXW
  • FPAY
  • Stock Information
  • Founded
  • BCTXW N/A
  • FPAY 2003
  • Country
  • BCTXW Canada
  • FPAY United States
  • Employees
  • BCTXW 12
  • FPAY N/A
  • Industry
  • BCTXW Biotechnology: Pharmaceutical Preparations
  • FPAY Diversified Commercial Services
  • Sector
  • BCTXW Health Care
  • FPAY Consumer Discretionary
  • Exchange
  • BCTXW Nasdaq
  • FPAY Nasdaq
  • Market Cap
  • BCTXW N/A
  • FPAY 46.4M
  • IPO Year
  • BCTXW N/A
  • FPAY N/A
  • Fundamental
  • Price
  • BCTXW $0.29
  • FPAY $1.66
  • Analyst Decision
  • BCTXW
  • FPAY Strong Buy
  • Analyst Count
  • BCTXW 0
  • FPAY 2
  • Target Price
  • BCTXW N/A
  • FPAY $3.25
  • AVG Volume (30 Days)
  • BCTXW N/A
  • FPAY 138.3K
  • Earning Date
  • BCTXW N/A
  • FPAY 11-14-2024
  • Dividend Yield
  • BCTXW N/A
  • FPAY N/A
  • EPS Growth
  • BCTXW N/A
  • FPAY N/A
  • EPS
  • BCTXW N/A
  • FPAY N/A
  • Revenue
  • BCTXW N/A
  • FPAY $134,563,007.00
  • Revenue This Year
  • BCTXW N/A
  • FPAY $25.78
  • Revenue Next Year
  • BCTXW N/A
  • FPAY $6.46
  • P/E Ratio
  • BCTXW N/A
  • FPAY N/A
  • Revenue Growth
  • BCTXW N/A
  • FPAY 24.46
  • 52 Week Low
  • BCTXW N/A
  • FPAY $0.97
  • 52 Week High
  • BCTXW N/A
  • FPAY $2.19
  • Technical
  • Relative Strength Index (RSI)
  • BCTXW N/A
  • FPAY 49.76
  • Support Level
  • BCTXW N/A
  • FPAY $1.43
  • Resistance Level
  • BCTXW N/A
  • FPAY $1.69
  • Average True Range (ATR)
  • BCTXW 0.00
  • FPAY 0.15
  • MACD
  • BCTXW 0.00
  • FPAY -0.02
  • Stochastic Oscillator
  • BCTXW 0.00
  • FPAY 52.63

About BCTXW BriaCell Therapeutics Corp. Warrant

BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

Share on Social Networks: